USNA News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

US

Mkt Cap

$284.2M

Volume

160.41K

Next Earnings

October 28th

Chart Financials Earnings News About Insider Filings

Why Usana Health Sciences Stock Plummeted This WeekUsana Health Sciences stock declined 30% this week following disappointing Q2 results. The company reported adjusted earnings of $0.07 per share and sales of $223 million, both significantly below analyst expectations. Usana announced a $29 million goodwill impairment charge on its Hiya business and revised full-year guidance to expect an $11 million loss instead of a $20-27 million profit. Full-year sales guidance was also lowered from $925-1 billion to $910 million.The Motley Fool · Aug 9, 2026

Format Innovation Reshapes a $438B Functional MarketThe global functional food and beverage market is projected to reach $438 billion in 2026, with oral pouches and alternative caffeine delivery formats driving growth. Doseology Sciences launched caffeine-based energy pouches under its Feed That Brain brand, while Kraft Heinz introduced the HEINZ KegChup, Tilray Brands expanded spirits distribution in Illinois, Cronos Group launched Lord Jones cannabis in Israel, and USANA Health Sciences reported strong 2025 sales with positive 2026 guidance.Benzinga · Feb 13, 2026

The Compliance Imperative: Regulatory Moats Driving 2026 Asset Re-RatingsThe global consumer healthcare market is experiencing a structural shift where regulatory compliance and FDA approval have become critical competitive advantages. Major companies including Philip Morris, Celsius Holdings, USANA Health Sciences, and Medifast are advancing strategic initiatives focused on regulatory readiness, product integration, and market expansion. Doseology Sciences has partnered with McKinney Regulatory Science Advisors to strengthen its FDA pathway for oral pouch products.Benzinga · Jan 19, 2026

Women Health & Beauty Supplements Market Analysis and Growth Forecast 2026-2030The global women's health and beauty supplements market is experiencing robust growth, expanding from USD 62.42 billion in 2024 to USD 66.38 billion in 2025, with projections to reach USD 91.42 billion by 2030 at a CAGR of 6.56%. Key growth drivers include ingredient innovation (collagen, probiotics, adaptogens), format evolution (gummies, powders), direct-to-consumer engagement, and regional localization strategies. The market is characterized by a mixed ecosystem of legacy manufacturers, emerging digital brands, and ingredient innovators leveraging strategic partnerships for competitive advantage.GlobeNewswire Inc. · Jan 19, 2026

Stock Market Today: Dow Jones, Nasdaq, S&P 500 Futures Advance— Applied Digital, Stellantis, Elastic In Focus (UPDATED)U.S. stock futures rose on Friday after Thursday's market decline, with corporate earnings providing mixed results. Key focus was on potential trade discussions between U.S. and China, and market expectations of potential Federal Reserve interest rate cuts.Benzinga · Oct 10, 2025

Xencor Surges 10.5%: Is This an Indication of Further Gains?Xencor shares surged 10.5% after the company announced a secondary stock offering to raise $175 million. The company plans to use the funds to support its pipeline development. However, earnings and revenue expectations for the upcoming quarter are negative, which may impact the stock's future performance.Benzinga · Sep 12, 2024

Multivitamins Show No Link To 'Lower Risk of Death,' Study FindsTaking a multivitamin once a day has long been considered a path to better health, but a new study refutes that widely held belief. A study published in JAMA Network Open on Wednesday revealed that after tracking nearly 400,000 healthy adults for over 20 years, researchers found no link between regular multivitamin use and a lower risk of death, according to the National Institutes of Health. The study was led by researchers at the National Institutes of Health's National Cancer Institute. Also Read: Healthcare Advocates United: A Push For Congress To Recognize CBD As Dietary Supplements “The analysis showed ...Full story available on Benzinga.comBenzinga · Jun 27, 2024

USNA or ZTS: Which Is the Better Value Stock Right Now?USNA vs. ZTS: Which Stock Is the Better Value Option?Zacks Investment Research · Jun 21, 2024

USNA vs. ZTS: Which Stock Is the Better Value Option?USNA vs. ZTS: Which Stock Is the Better Value Option?Zacks Investment Research · Jun 5, 2024

USNA vs. STVN: Which Stock Should Value Investors Buy Now?USNA vs. STVN: Which Stock Is the Better Value Option?Zacks Investment Research · May 20, 2024

US

USNAUSANA Health Sciences Inc

USNA

Pay with—

Available Balance0.00

Your PositionYou don't own any USNA yet.

Related Tickers

Earnings